Effects of the antihistamine diphenhydramine on selected aquatic organisms

Environmental Toxicology and Chemistry

Volumn 30, Issue 9, 2011, Pages 2065-2072

  Berninger, Jason P ^a   Du, Bowen ^a   Connors, Kristin A ^a   Eytcheson, Stephanie A ^a   Kolkmeier, Mark A ^a   Prosser, Krista N ^a   Valenti Jr , Theodore W ^a   Chambliss, C Kevin ^a   Brooks, Bryan W ^a  

^a BAYLOR UNIVERSITY   (United States)

Author keywords

Comparative pharmacology; Diphenhydramine; Environmental risk assessment; Pharmaceutical effects; Prioritization

Indexed keywords

COMPARATIVE PHARMACOLOGY; DIPHENHYDRAMINE; ENVIRONMENTAL RISK ASSESSMENT; PHARMACEUTICAL EFFECTS; PRIORITIZATION;

ANOXIC SEDIMENTS; EFFLUENTS; FISH; MAMMALS; RISK ASSESSMENT; SEWAGE; TISSUE; TOXICITY;

PH EFFECTS;

ACETYLCHOLINE; DIPHENHYDRAMINE;

BASELINE CONDITIONS; CRUSTACEAN; CYPRINID; DRUG; EFFLUENT; ENVIRONMENTAL ASSESSMENT; FEEDING BEHAVIOR; INDUSTRIAL WASTE; MONOCOTYLEDON; MORTALITY; PH; PRIORITIZATION; RISK ASSESSMENT; TOXICITY; TOXICOLOGY;

AQUATIC SPECIES; ARTICLE; DAPHNIA; FEEDING BEHAVIOR; FISH; INVERTEBRATE; LEMNA; MORTALITY; NONHUMAN; PH; PIMEPHALES PROMELAS; PLANT; PRIORITY JOURNAL; SURVIVAL;

ANIMALS; ANTI-ALLERGIC AGENTS; AQUATIC ORGANISMS; ARACEAE; CYPRINIDAE; DAPHNIA; DIPHENHYDRAMINE; FRESH WATER; HYDROGEN-ION CONCENTRATION; REPRODUCTION; RISK ASSESSMENT; WATER POLLUTANTS, CHEMICAL;

DAPHNIA; DAPHNIA MAGNA; INVERTEBRATA; LEMNA GIBBA; MAMMALIA; PIMEPHALES PROMELAS;

EID: 80054841956     PISSN: 07307268     EISSN: 15528618     Source Type: Journal    
DOI: 10.1002/etc.590     Document Type: Article

References (48)

1. Brooks BW, Riley TM, Taylor RD. 2006. Water quality of effluent-dominated ecosystems: ecotoxicological, hydrological, and management considerations. Hydrobiologia 556: 365-379.
2. Ramirez AJ, Brain RA, Usenko S, Mottaleb MA, O'Donnell JG, Stahl LL, Wathen JB, Snyder BD, Pitt JL, Perez-Hurtado P, Dobbins LL, Brooks BW, Chambliss CK. 2009. Occurrence of pharmaceuticals and personal care products in fish: Results of a national pilot study in the United States. Environ Toxicol Chem 28: 2587-2597.
3. Ankley GT, Brooks BW, Huggett DB, Sumpter JP. 2007. Repeating history: Pharmaceuticals in the environment. Environ Sci Technol 41: 8211-8217.
4. Brooks BW, Huggett DB, Boxall ABA. 2009. Pharmaceuticals and personal care products: Research needs for the next decade. Environ Toxicol Chem 28: 2469-2472.
5. Berninger JP, Brooks BW. 2010. Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals. Toxicol Lett 193: 69-78.
6. Stackelberg PE, Furlong ET, Meyer MT, Zaugg SD, Henderson HK, Reissman DB. 2004. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water treatment plant. Sci Total Environ 329: 99-113.
7. Ferrer I, Heine CE, Thurman EM. 2004. Combination of LC/TOF-MS and LC/ion trap MS/MS for the identification of diphenhydramine in sediment samples. Anal Chem 76: 1437-1444.
8. Ramirez AJ, Mottaleb MA, Brooks BW, Chambliss CK. 2007. Analysis of pharmaceuticals in fish using liquid chromatography-tandem mass spectrometry. Anal Chem 79: 3155-3163.
9. Zhou SN, Oakes KD, Servos MR, Pawliszyn J. 2008. Application of solid-phase microextraction for in vivo laboratory and field sampling of pharmaceuticals in fish. Environ Sci Technol 42: 6073-6079.
10. Au-Yeung SCS, Rurak DW, Gruber N, Riggs KW. 2006. A pharmacokinetic study of diphenhydramine transport across the blood-brain barrier in adult sheep: Potential involvement of a carrier-mediated mechanism. Drug Metab Dispos 34: 955-960.
11. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. 2011. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 39: D1035-1041.
12. Beijersbergen van Henegouwen GMJ, Van de Zijde HJ, Van de Griend J, De Vries H. 1987. Photochemical decomposition of diphenhydramine in water. Int J Pharm 35: 259-262.
13. Boreen AL, Arnold WA, McNeill K. 2003. Photodegradation of pharmaceuticals in the aquatic environment: A review. Aquat Sci 65: 320-341.
14. Kosonen J, Kronberg K. 2009. The occurrence of antihistamines in sewage waters and in recipient rivers. Environ Sci Pollut Res Int 16: 555-564.
15. Heberer T. 2002. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: A review of recent research data. Toxicol Lett 131: 5-17.
16. Daughton CG, Brooks BW. 2011. Active pharmaceuticals ingredients and aquatic organisms. In Meador J, Beyer N, eds, Environmental Contaminants in Wildlife: Interpreting Tissue Concentrations, 2nd ed. CRC, Boca Raton, FL, USA, pp 281-341.
17. van Wezel AP, Opperhuizen A. 1995. Narcosis due to environmental pollutants in aquatic organisms: Residue-based toxicity, mechanisms, and membrane burdens. Crit Rev Toxicol 25: 255-279.
18. Gunnarsson L, Jauhiainen A, Kristiansson E, Nerman O, Larsson DGJ. 2008. Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ Sci Technol 42: 5807-5813.
19. Brown NJ, Roberts LJ II. 2001. Histamine, bradykinin, and their antagonists. In Hardman JG, Limbird LE, eds, Goodman and Gilman's Pharmacological Basis of Therapeutics, 10th ed. McGraw Hill, New York, NY, USA, p 656.
20. Wong DT, Perry KW, Bymaster FP. 2005. The discovery of fluoxetine hydrochloride (Prozac). Natl Rev Drug Disc 4: 764-774.
21. Bird SB, Gaspari RJ, Lee WJ, Dickson EW. 2002. Diphenhydramine as a protective agent in rat model of acute, lethal organophosphate poisoning. Acad Emerg Med 9: 1369-1372.
22. Huggett DB, Cook JC, Ericson JF, Williams RT. 2003. A theoretical model for utilizing mammalian pharmacological and safety data to prioritize potential impacts of human pharmaceuticals to fish. Hum Ecol Risk Assess 9: 1789-1799.
23. U.S. Environmental Protection Agency. 2002. Methods for measuring the acute toxicity of effluents and receiving waters to freshwater and marine organisms, 5th ed. EPA-821-R- 020-012. Office of Research and Development, Washington DC.
24. American Public Health Association, American Water Works Association, Water Environment Foundation. 1998. Standard Methods for the Examination of Water and Wastewater, 20th ed. American Public Health Association, Washington, DC.
25. U.S. Environmental Protection Agency. 2002. Short-term methods for estimating the chronic toxicity of effluents and receiving waters to freshwater organisms. EPA-821-R-02-013. Office of Research and Development, Washington, DC.
26. Organization for Economic Co-operation and Development. 2008. Daphnia magna Reproduction Test. Test 211. In OECD Guidelines for the Testing of Chemicals, Section 2: Effects on Biotic Systems. Paris, France.
27. Valenti TW, Perez-Hurtado P, Chambliss CK, Brooks BW. 2009. Aquatic toxicity of sertraline to Pimephales promelas at environmentally relevant surface water pH. Environ Toxicol Chem 28: 2685-2694.
28. U.S. Environmental Protection Agency. 2009. Estimation Programs Interface Suite™ for Microsoft® Windows, ver 4.00. Washington, DC.
29. Stanley JK, Ramirez AJ, Chambliss CK, Brooks BW. 2007. Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. Chemosphere 69: 9-16.
30. Fitzsimmons PN, Fernadez JD, Hoffman AD, Butterworth BC, Nichols JW. 2001. Branchial elimination of superhydrophobic organic compounds by rainbow trout (Oncorhynchus mykiss). Aquat Toxicol 5: 23-34.
31. Scherrer RA, Howard SM. 1977. Use of distribution coefficients in quantitative structure-activity relationships. J Med Chem 20: 53-58.
32. Fick J, Lindberg RH, Tysklind M, Larsson DGJ. 2010. Predicted critical environmental concentrations for 500 pharmaceuticals. Reg Toxicol Pharm 58: 516-523.
33. U.S. Environmental Protection Agency. 1994. 10-day chronic toxicity test using Daphnia magna or Daphnia pulex. Compendium of ERT Standard Operating Protocols, SOP 2028. Office of Solid Waste and Emergency Response, Edison, NJ.
34. Dzialowski EM, Turner PK, Brooks BW. 2006. Physiological and reproductive effects of beta adrenergic receptor antagonists on Daphnia magna. Arch Environ Contam Toxicol 50: 503-510.
35. Stanley JK, Ramirez AJ, Mottaleb M, Chambliss CK, Brooks BW. 2006. Enantio-specific toxicity of the b-blocker propranolol to Daphnia magna and Pimephales promelas. Environ Toxicol Chem 25: 1780-1786.
36. Hemming JM, Turner PK, Brooks BW, Waller WT, La Point TW. 2002. Assessment of toxicity reduction in wastewater effluent flowing through a treatment wetland using Pimephales promelas, Ceriodaphnia dubia, and Vibrio fischeri. Arch Environ Contam Toxicol 42: 9-16.
37. Brain RA, Solomon KR. 2007. A protocol for conducting 7-day daily renewal tests with Lemna gibba. Nat Protocols 2: 979-987.
38. Brain RA, Hanson ML, Solomon KR, Brooks BW. 2008. Aquatic plants exposed to pharmaceuticals: Effects and risks. Rev Environ Contam Toxicol 192: 67-115.
39. Nakamura Y, Yamamoto H, Sekizawa J, Kondo T, Hirai N, Tatarazako N. 2008. The effects of pH on fluoxetine in Japanese medaka (Oryzias latipes): Acute toxicity in fish larvae and bioaccumulation in juvenile fish. Chemosphere 70: 865-873.
40. Gould GG, Brooks BW, Frazer A. 2007. [3H] citalopram binding to serotonin transporter sites in minnow brains. Basic Clin Pharmacol Toxicol 101: 203-210.
41. Minagh E, Hernan R, O'Rourke K, Lyng FM, Davoren M. 2009. Aquatic ecotoxicity of the selective serotonin reuptake inhibitor sertraline hydrochloride in a battery of freshwater test species. Ecotoxicol Environ Saf 72: 434-440.
42. Brooks BW, Foran CM, Richards SM, Weston J, Turner PK, Stanley JK, Solomon KR, Slattery M, La Point TW. 2003. Aquatic ecotoxicology of fluoxetine. Toxicol Lett 142: 169-183.
43. Oakes K, Coors A, Escher B, Fenner K, Garric J, Gust M, Knacker T, Kuster A, Kussatz C, Metcalfe C, Monteiro S, Moon T, Parrott J, Pery A, Ramil M, Tarazona JV, Sanchez Arguello P, Ternes T, Trudeau V, Van Der Kraak G, Servos M. 2010. An environmental risk assessment for the serotonin re-uptake inhibitor fluoxetine: A case study utilizing the European risk assessment framework. Integr Environ Assess Manag 6: 524-539.
44. Meinertz JR, Schreier TM, Bernardy JA, Franz JL. 2010. Chronic toxicity of diphenhydramine hydrochloride and erythromycin thiocyanate to daphnia, Daphnia magna, in a continuous exposure test system. Bull Environ Contam Toxicol 85: 447-451.
45. Carvalho FD, Machado I, Martýnez MS, Soares A, Guilhermino L. 2003. Use of atropine-treated Daphnia magna survival for detection of environmental contamination by acetylcholinesterase inhibitors. Ecotoxicol Environ Saf 53: 43-46.
46. Haas HL, Sergeeva OA, Selbach O. 2008. Histamine in the nervous system. Physiol Rev 88: 1183-1241.
47. Orzechowski RF, Currie DS, Valancius CA. 2005. Comparative anticholinergic activities of 10 histamine H1 receptor antagonists in two functional models. Eur J Pharmacol 506: 257-264.
48. Raimondo S, Montague BJ, Barron MG. 2007. Determinants of the variability in acute to chronic toxicity ratios for aquatic invertebrates and fish. Environ Toxicol Chem 26: 2019-2023.